Form 4: Elanco Director Receives Equity Award

R. David Hoover, a Director at Elanco Animal Health Inc., received a grant of deferred stock units as part of an annual equity award.

Summary

• R. David Hoover, a Director at Elanco Animal Health Inc. (ELAN), was granted 4,678 deferred stock units on May 21, 2026.
• This grant is described as a pro-rated annual equity award for non-employee board members.
• Following this transaction, Hoover beneficially owns 111,451 shares of common stock, with some held indirectly through trusts.

Sentiment

Score: 5

Explanation: StockSavvy.ai views this as a neutral filing, as it reports a routine equity award to a director rather than significant financial performance or strategic changes.

Positives

• Director R. David Hoover received an equity award, indicating continued incentive alignment with the company.
• The award is part of a standard annual equity program for non-employee directors.

Future Outlook

No specific forward-looking statements or guidance are present in this filing.

Industry Context

StockSavvy.ai notes that equity awards to directors are a common practice in the animal health industry to align executive and board interests with shareholder value.

Stakeholder Impact

• Shareholders: The equity award aligns director incentives with long-term shareholder value creation, a standard governance practice.

Key Dates

Keywords

Elanco Animal Health, ELAN, Form 4, SEC Filing, Director Compensation, Equity Award, Deferred Stock Units, Beneficial Ownership